Form 4: SeaStar Medical Holding Corp: Chief Medical Officer Kevin Chung Reports Acquisition of 15,000 Restricted Stock Units

Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp, reports the acquisition of 15,000 Restricted Stock Units (RSUs) on April 1, 2025, vesting over three years.

Summary

• On April 3, 2025, Kevin Chung, the Chief Medical Officer of SeaStar Medical Holding Corp, filed a Form 4.
• The form reports a transaction that occurred on April 1, 2025, where Mr. Chung acquired 15,000 Restricted Stock Units (RSUs).
• These RSUs represent a contingent right to receive one share of ICU common stock each.
• The RSUs will vest in equal installments on the first, second, and third anniversaries of April 1, 2025.
• Following the reported transaction, Mr. Chung directly owns 15,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock options, which doesn't inherently indicate positive or negative sentiment, but the vesting schedule suggests a long-term commitment.

Positives

• The acquisition of RSUs by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or future prospects, but the vesting schedule of the RSUs suggests a multi-year commitment from the executive.

Industry Context

This is a standard regulatory filing related to executive compensation. It doesn't provide specific insights into SeaStar Medical's competitive position or broader industry trends.

Stakeholder Impact

• The granting of RSUs to a key executive aligns their interests with those of the shareholders, potentially incentivizing them to improve company performance.

Key Dates

Keywords

Form 4, SeaStar Medical Holding Corp, Kevin Chung, Restricted Stock Units, RSUs, Beneficial Ownership, ICU, Chief Medical Officer, Vesting